Researchers have developed a new eye drop that combines two active agents, pilocarpine and diclofenac, to help patients with presbyopia, a age-related difficulty in focusing on near objects. The study found that the treatment improved vision for up to two years and was well-tolerated by patients. The eye drops work by constricting the pupils and contracting the ciliary muscle, which helps the eye focus on objects at varying distances. This non-surgical alternative to glasses could revolutionize presbyopia care and provide a convenient option for patients who want to reduce their dependence on reading glasses.
Source: https://www.sciencedaily.com/releases/2025/09/250914205832.htm